Nishimura T, Suzukawa M, Oshima N, Tashimo H, et al. Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumab. J Asthma 2026 Feb 19:1-13. doi: 10.1080/02770903.2026.2633364.
PMID: 41712271